BiotechTube
Home/Legend Biotech/Ying Huang, Ph.D.
YH

Ying Huang, Ph.D.

Chief Executive Officer

Legend Biotech

Therapeutic Areas

OncologyHematology

Legend Biotech Pipeline

DrugIndicationPhase
Ciltacabtagene Autoleucel (cilta-cel)Relapsed/Refractory Multiple MyelomaApproved / Phase 3
LB1901Relapsed/Refractory T-cell LymphomaPhase 1
LB2101Extensive-Stage Small Cell Lung CancerPhase 1
LB2102ES-SCLC & Neuroendocrine CancersPhase 1
LB1908Gastric, Pancreatic & Other CancersPhase 1
LUCAR-20SRelapsed/Refractory Multiple MyelomaPhase 1

Leadership Team at Legend Biotech

LM
Lori Macomber, CPA
Chief Financial Officer
LP
Lida Pacaud, M.D.
Chief Medical Officer
FZ
Frank Zhang, Ph.D.
Chief Scientific Officer
RI
Ramy Ibrahim, M.D.
President, Cell Therapy Group
SG
Steve Gavel
Chief Commercial Officer, Cell Therapy
View full Legend Biotech profile